STAT3 and hepatocellular carcinoma: TAM-derived IL-6 and mitogens promote the occurrence and development of hepatocellular carcinoma via activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa B (NF-κB) signaling, respectively, which also promote resistance to chemotherapy [22,23].